Elicio Therapeutics, Inc. (ELTX) stock
ELTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.50−0.06 (-3.85%)
Close on Nov 13, 2026Market cap $39.42MP/E –Yield –
Elicio Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Elicio Therapeutics's enterprise value was $21.75M on Nov 11, 2026, against $150.65M a year earlier. Over the last 5 years it ranged from -$94.23M to $222.07M, with a median of $36.69M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $21.75M | -82.8% |
| 2025 | Dec 31, 2025 | $126.49M | +336.4% |
| 2024 | Dec 31, 2024 | $28.98M | -47.3% |
| 2023 | Dec 29, 2023 | $55.03M | +7401.5% |
| 2022 | Dec 30, 2022 | $733.65K | – |
| 2021 | Dec 31, 2021 | -$93.60M | – |
See a number that looks wrong?